ACE1702 / Acepodia 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ACE1702 / Acepodia
NCT04319757: ACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid Tumors

Completed
1
12
US, RoW
ACE1702, Cyclophosphamide, Fludarabine
Acepodia Biotech, Inc.
Locally Advanced Solid Tumor, Metastatic Cancer, Solid Tumor, HER2-positive Gastric Cancer, HER2-positive Metastatic Breast Cancer
07/24
07/24

Download Options